Litigation Details for Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. (D. Del. 2019)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. (D. Del. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-10-29 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 8,101,659; 8,796,331; 8,877,938; 9,388,134 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc.
Details for Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-05-19 | Zydus infringement trial concerning U.S. Patent Nos. 8,101,659, 8,796,331, 8,877,938 and 9,388,134 to May… 29 October 2019 1:19-cv-02053 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | ||
2022-05-04 | 252 | Stipulation to EXTEND Time | infringement trial concerning U.S. Patent Nos. 8,101,659; 8,796,331; 8,877,938; and 9,388,134 in accordance… 29 October 2019 1:19-cv-02053 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-05-10 | 253 | Stipulation-General (See Motion List for Stipulation to Extend Time) | Regarding Defendant DRL's Infringement of U.S. Patent No. 8,796,331 by Novartis Pharmaceuticals Corporation.… 29 October 2019 1:19-cv-02053 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-05-10 | 254 | Order | Regarding Defendant DRL's Infringement of U.S. Patent No. 8,796,331. Signed by Judge Richard G. Andrews on 5… 29 October 2019 1:19-cv-02053 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |